Quince Therapeutics
QNCX
#9474
Rank
A$90.24 M
Marketcap
$2.05
Share price
-1.59%
Change (1 day)
29.91%
Change (1 year)

Earnings for Quince Therapeutics (QNCX)

Earnings in 2024 (TTM): -A$55.13 Million

According to Quince Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$44.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quince Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -A$59.83 Million33.58%
2023 -A$44.79 Million-47.15%
2022 -A$84.75 Million-43.27%
2021 -A$0.15 Billion17.53%
2020 -A$0.13 Billion99.1%
2019 -A$63.85 Million235.08%
2018 -A$19.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion 295.06%๐Ÿ‡บ๐Ÿ‡ธ USA